Mérieux Equity Partners
Venture capitalParis · Seed–Late Stage · 14 people tracked
Find your way into Mérieux Equity Partners
974 people in our graph share verified history with the Mérieux Equity Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
The firm focuses exclusively on the healthcare sector, leveraging deep expertise and a broad industry network. It invests through two strategies: an Innovation platform backing innovative medical solutions from seed to Series B (via Mérieux Innovation 2, with checks of €3m to €15m), and a Buyout platform supporting more established companies (via Mérieux Participations 5, with checks of €20m to €80m, more with co-investment). Both target companies across Europe, ranging from start-ups to established sector leaders.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from curated & public directories
What they invest in
from 17 of 17 portfolio companiesMedical Devices ×10Biotech ×8Healthtech ×8AI & Machine Learning ×5Digital Health ×4Deep Tech ×3Advanced Manufacturing ×2Hardware ×2
HQs:France×5Switzerland×2Spain×2Germany×1Finland×1Netherlands×1
Investments · 17 tracked
founders shown can be your intro pathCeva is a global animal health company specializing in vaccines, reproductive management products, and behavioral control solutions for livestock and companion animals.
AgTechBiotechHealthtechLibourne, FR
Amir Panush(Chief Executive Officer and Director)Dr Marc Prikazsky(CEO)
Co-investorsArchiMed Pte. Ltd.Continental Grain CompanyEMZ PartnersMitsui & CoSagardTemasek+1 more
Prothea Technologies develops fluorescence imaging and optical sensing technologies for respiratory medicine and oncology applications.
BiotechHealthtechMedical Devices
Kev(Director & Chief Scientific and Medical Officer)
Co-investorsKorysEarlybird Venture CapitalOld College Capital
Swixx BioPharma is a specialized pharmaceutical distributor and market access partner that represents international biopharma, OTC, and medical device companies in markets across Central & Eastern Europe, the Middle East, North Africa, Latin America, and Eurasia.
BiotechHealthtechMedical DevicesBaar, CH
Co-investorsBain Capital Life SciencesHBM PartnersSK Capital PartnersHBM Healthcare Investments
AcuSurgical develops robotic systems for vitreoretinal ophthalmic surgery, enabling surgeons to perform complex microsurgeries with enhanced precision and control.
Deep TechHealthtechMedical DevicesRoboticsMontpellier, FR
Vivian Smith(Founder)in
Co-investorsKorysSupernova Invest
Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.
AI & Machine LearningBiotechDeep Tech
Co-investorsFirst In VenturesHeran PartnersIllumina VenturesKorys
Corflow develops diagnostic and therapeutic solutions to restore healthy microvascular blood flow in the human body, serving the cardiovascular medical device industry.
HardwareHealthtechMedical Devices
Martin(Physician Co-Founder)Rick Geoffrion(Chairman and CEO)
Co-investors415 CapitalBroadview VenturesLaerdal Million Lives FundPanakes PartnersKorys
curea medical GmbH manufactures MPD wound dressings, including SuperCore absorption cores made of cellulose, cotton, and sodium polyacrylate for palliative wound care.
HealthtechMedical Devices
DentalMonitoring offers an AI platform that analyzes smartphone-captured intraoral images to detect and report on 130 oral events, assisting dental professionals with remote observation and monitoring of orthodontic treatments.
AI & Machine LearningDigital HealthMedical Devices
Philippe Salah(Founder)in
Co-investorsAdelieVitruvian Partners
Health in Code is a genetic diagnostics laboratory that performs full genetic studies, variant interpretation, and clinical-genetic reporting, and develops and manufactures disease diagnostic kits for specialized labs.
BiotechDigital HealthMedical Devices
Keranova is a medtech company developing FemtoMatrix, a robotic surgical platform for eye surgery that uses vision, artificial intelligence, and precise robotic movements to automate cataract procedures via laser Photoemulsification.
AI & Machine LearningMedical DevicesRoboticsSaint-Étienne, FR
Denise Hoblingre(CEO)inAurélien Bernard(PhD, Chief Scientific Officer)inEmmanuel Baubeau(PhD, Chief Technical Officer)
Co-investorsSupernova InvestBpifranceCEA Investissement
Lab Quality provides external quality assessment (EQA) programs for medical laboratories and point-of-care testing sites, offering over 250 clinically relevant quality assessment schemes compliant with ISO 15189 standards.
Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSHelsinki, FI
Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.
AI & Machine LearningCloud ComputingDeveloper Tools
Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesAlta Life SciencesAsabys Partners+4 more
WE ARE ONA is a creative culinary studio that designs bespoke dining experiences for luxury and artistic brands, combining strategy, design, and production to reinforce emotional connections between brands and their audiences.
ConsumerFoodTechMarketplacesParis, FR
Luca Pronzato(Founder)
Co-investorsWind VentureColumbus Venture PartnersKorysYsios Capital
Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.
BiotechHealthtechMedical Devices
Co-investorsFund+KorysYsios CapitalAlta Life SciencesAsabys PartnersBpifrance+2 more
SeqOne provides a clinical genomics analysis platform for germline and somatic variant interpretation across panels, exomes, and genomes, supporting short and long-read sequencing.
AI & Machine LearningBiotechDigital Health
Nicolas Philippe(Founder)in
Co-investorsSupernova InvestElaia
Exits · 1
1 IPOsCevaNASDAQ: CEVA
Portfolio news
latest coverage across their companiesAcuSurgical · tipranks.com · Aug 19, 2026
Ona Therapeutics · fiercebiotech.com · Aug 12, 2026
Ona · ddw-online.com · Jun 5, 2026
Swixx Biopharma · investorsinhealthcare.com · Dec 15, 2025
SeqOne · blog.congenica.com · Sep 2, 2025
Frequently asked questions
- How many investments has Mérieux Equity Partners made?
- Mérieux Equity Partners has 17 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Mérieux Equity Partners invest at?
- Mérieux Equity Partners invests at the Seed, Series A, Series B, Growth, Late Stage stages.
- What is Mérieux Equity Partners's typical check size?
- Mérieux Equity Partners typically writes checks of $3.2M – $86M.
- What sectors does Mérieux Equity Partners focus on?
- Mérieux Equity Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Mérieux Equity Partners located?
- Mérieux Equity Partners is headquartered in Paris, FR.
- Does Mérieux Equity Partners lead rounds?
- Yes, Mérieux Equity Partners leads investment rounds.
- Who does Mérieux Equity Partners co-invest with?
- Mérieux Equity Partners most often shares deals with Korys, Broadview Ventures, Heran Partners, among 9 tracked co-investors.
Images
Similar investors
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Bay City Capital is a venture capital firm founded in 1997 that has raised five venture funds totaling $1.3 billion in capital commitments and invested in more than 100 companies worldwide.
Aescuvest is a European healthtech investment firm that sources, structures, and co-invests in healthtech financing rounds through dedicated single-deal SPVs, alongside business angels, family offices, and corporate partners.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.
Clal Biotechnology Industries (TASE: CBI) is an Israeli life sciences investment firm listed on the Tel Aviv Stock Exchange, focused on identifying and developing ventures that create proprietary solutions for unmet medical needs.